ATE141929T1 - Verfahren zur herstellung von epoxy-hepariden; die so hergestellten produkte und diese enthaltende pharmazeutische zusammensetzungen - Google Patents

Verfahren zur herstellung von epoxy-hepariden; die so hergestellten produkte und diese enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE141929T1
ATE141929T1 AT91118366T AT91118366T ATE141929T1 AT E141929 T1 ATE141929 T1 AT E141929T1 AT 91118366 T AT91118366 T AT 91118366T AT 91118366 T AT91118366 T AT 91118366T AT E141929 T1 ATE141929 T1 AT E141929T1
Authority
AT
Austria
Prior art keywords
heparides
pharmaceutical compositions
products
produced
compositions containing
Prior art date
Application number
AT91118366T
Other languages
English (en)
Inventor
Luigi De-Ambrosi
Original Assignee
Derivati Organici Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Derivati Organici Lab filed Critical Derivati Organici Lab
Application granted granted Critical
Publication of ATE141929T1 publication Critical patent/ATE141929T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Epoxy Compounds (AREA)
AT91118366T 1990-10-29 1991-10-28 Verfahren zur herstellung von epoxy-hepariden; die so hergestellten produkte und diese enthaltende pharmazeutische zusammensetzungen ATE141929T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02190990A IT1243987B (it) 1990-10-29 1990-10-29 Procedimento per la preparazione di epossi-eparidi prodotti ottenuti ecomposizioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
ATE141929T1 true ATE141929T1 (de) 1996-09-15

Family

ID=11188614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91118366T ATE141929T1 (de) 1990-10-29 1991-10-28 Verfahren zur herstellung von epoxy-hepariden; die so hergestellten produkte und diese enthaltende pharmazeutische zusammensetzungen

Country Status (7)

Country Link
US (1) US5403827A (de)
EP (1) EP0483733B1 (de)
JP (1) JPH04288301A (de)
AT (1) ATE141929T1 (de)
CA (1) CA2054347A1 (de)
DE (1) DE69121666D1 (de)
IT (1) IT1243987B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296471A (en) * 1992-12-22 1994-03-22 Glycomed Incorporated Method for controlling o-desulfation of heparin and compositions produced thereby
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
US20020040008A1 (en) * 1995-01-24 2002-04-04 Wagner Denisa D. Method for treating and preventing atherosclerosis
US5891196A (en) * 1997-04-16 1999-04-06 Baxter International Inc. Method for actively binding heparin to crosslinked biological tissues
RU2129001C1 (ru) * 1998-06-03 1999-04-20 Всероссийский научно-исследовательский институт мясной промышленности Средство для лечения атеросклероза "алиприл"
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
US8569262B2 (en) * 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
EP2205642B1 (de) * 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Nicht gerinnungshemmende polysaccharidzusammensetzungen
US8592393B2 (en) * 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8435795B2 (en) * 2010-01-19 2013-05-07 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
BR112012026542A2 (pt) 2010-04-16 2016-07-12 Momenta Pharmaceuticals Inc abordagem seletiva de tecido
WO2011159770A2 (en) 2010-06-17 2011-12-22 Momenta Pharmaceuticals, Inc. Methods and compositions for modulating hair growth
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2014193818A1 (en) 2013-05-28 2014-12-04 Momenta Pharmaceuticals, Inc. Pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179566A (en) * 1963-05-16 1965-04-20 Canada Packers Ltd Purification of heparin
FR2538404B1 (de) * 1982-12-28 1985-08-23 Anic Spa
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US4981955A (en) * 1988-06-28 1991-01-01 Lopez Lorenzo L Depolymerization method of heparin

Also Published As

Publication number Publication date
IT1243987B (it) 1994-06-28
US5403827A (en) 1995-04-04
EP0483733B1 (de) 1996-08-28
IT9021909A0 (it) 1990-10-29
CA2054347A1 (en) 1992-04-30
IT9021909A1 (it) 1992-04-29
EP0483733A1 (de) 1992-05-06
DE69121666D1 (de) 1996-10-02
JPH04288301A (ja) 1992-10-13

Similar Documents

Publication Publication Date Title
ATE141929T1 (de) Verfahren zur herstellung von epoxy-hepariden; die so hergestellten produkte und diese enthaltende pharmazeutische zusammensetzungen
DE58902737D1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
DE68910969D1 (de) Verfahren und vorrichtung zur herstellung von lipidbläschen.
DE69203959D1 (de) Verfahren zur Herstellung von Prepregs.
DE58906574D1 (de) Verfahren zur Herstellung von cyclischen Kohlensäureestern.
DE68903120D1 (de) Verfahren zur herstellung von zyklischen sulfaten.
DE69015391D1 (de) Verfahren zur Herstellung von Kunststoffteilchen.
DE68924619D1 (de) Stereolithographisches Verfahren zur Herstellung von Prothesen.
DE59008005D1 (de) Verfahren zur Herstellung von hochmolekularen Copolyarylensulfiden.
DE69121479D1 (de) Verfahren zur Herstellung von halogenierten 1,3-Dioxolanen und so erhaltenen Produkten
DE59007171D1 (de) Verfahren zur herstellung von sclareolid.
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
DE69004122D1 (de) Verfahren zur Herstellung eines Kalorienarmen Butterbrotaufstrichs und Erzeugnis.
DE69018215D1 (de) Verfahren zur Produktion von optisch aktivem Atenolol und Zwischenprodukt davon.
DE59001670D1 (de) Verfahren und anlage zur herstellung von dicalciumphosphat.
DE69009682D1 (de) Verfahren zur Herstellung von Cyclohexanolderivaten.
DE69008122D1 (de) Phenolnovolakharz, dessen härtungsprodukt und verfahren zur herstellung.
DE68922360D1 (de) Verfahren zur Herstellung von Metall-Polyimid-Verbundwerkstoffen.
DE68916396D1 (de) Verfahren zur Herstellung eines Carbonsäurealkenylesters.
DE58908205D1 (de) Verfahren zur Herstellung von opaken Chinacridonen.
DE68916760D1 (de) Verfahren zur Herstellung von Gamma-Lactonen.
DE69004170D1 (de) Verfahren zur Herstellung eines pflanzlichen Eiweisshydrolysats und so hergestelltes Produkt.
ATE189220T1 (de) Verfahren zur herstellung von 7-(3-amino- sowie 3-aminomethyl-1-pyrrolidinyl)-3-chinolon- carbonsäuren sowie -naphthyridoncarbonsäuren
DE69210069D1 (de) Verfahren zur Herstellung von 1,3-Dioxolen
DE68920087D1 (de) Verfahren zur Herstellung von Neuraminidase.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties